PDO Based Drug Sensitive Test in R/M SGC
To evaluate the consistency of drug efficacy between the clinical systemic treatment and drug sensitive test based on patient-derived organoid in R/M SGC patients, using a prospective and multicenter observational study to increase the generalizability and reliability of research conclusion.
Pathologically confirmed R/M SGC patients [+5]
Metastatic tumors in the head and neck region, or non-salivary gland cancer tumo... [+8]